Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Optimizing Personalized Management: Case Studies in Plaque Psoriasis Treatment : Episode 3

Opinion

Video

September 27, 2024

Role of PDE-4 in the Management of Plaque Psoriasis

Author(s):

Focusing on treatment paradigms in plaque psoriasis, E. James Song, MD, FAAD, provides insights on phosphodiesterase inhibitors 4 (PDE-4) and their role in the therapeutic landscape.

EP: 1.Evolution of Plaque Psoriasis Understanding, Pathophysiology, and Treatment Options

EP: 2.Morphological Differences of Plaque Psoriasis vs Eczema Skin Conditions

Now Viewing

EP: 3.Role of PDE-4 in the Management of Plaque Psoriasis

EP: 4.Management of Plaque Psoriasis in a 45-year-old Woman via Telemedicine

EP: 5.Optimizing Therapy Escalation: Navigating Insurance Barriers and Step Therapy for Patients with Plaque Psoriasis

EP: 6.Case 1: Evaluating Treatment History and Future Management Strategies for a Patient with Mild-to-Moderate Plaque Psoriasis

EP: 7.Comparison of Systemic Therapies for Plaque Psoriasis

EP: 8.Case 2: Management of a 58-Year-Old Patient with Location-Specific Plaque Psoriasis, Psoriatic Arthritis, Type 2 Diabetes, and Obesity

EP: 9.Defining Treatment Success with Oral Treatments in Patients with Plaque Psoriasis

EP: 10.Treatment Considerations for Patients with Skin and Joint Involvement in Plaque Psoriasis

EP: 11.Tailored Strategies and Evolving Therapies for Plaque Psoriasis

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!